Posted on Apr 3, 2025 by Cannacoin Blogger | blog.cannacoin.org
The escalating prevalence of cancers and allergies throughout the 20th century prompts a critical examination of potential contributing factors beyond conventional explanations such as industrial pollutants or dietary shifts. A seldom-discussed legislative intervention—the Marihuana Tax Act of 1937, often referred to as the Cannabis Stamp Act—may offer an overlooked perspective. This act effectively excised hemp from the American food chain, a plant historically integral to both human and animal nutrition (Gieringer, 1985). Could this removal have disrupted essential biological systems, precipitating the chronic health conditions we observe today? This article explores the historical context, nutritional significance, and emerging scientific evidence surrounding hemp’s absence, positing its potential role in the rise of malignancies and allergic disorders.
Historical Context: The Legislative Erasure of Hemp
Enacted on August 2, 1937, the Marihuana Tax Act imposed a prohibitive tax on all cannabis-related transactions, encompassing both marijuana and its non-psychoactive relative, hemp. Championed by Harry J. Anslinger, Commissioner of the Federal Bureau of Narcotics, the legislation emerged from a socio-political campaign against marijuana’s psychoactive properties, yet it indiscriminately curtailed hemp cultivation (Bonnie and Whitebread, 1970). Prior to this, hemp was a linchpin of American agriculture, valued for its fibrous utility in textiles and cordage, and plausibly as a livestock feed constituent, though primary evidence remains sparse (USDA, 1935). The act’s enforcement precipitated a precipitous decline in hemp production, severing its integration into the food chain by the late 1930s (Gieringer, 1985). This abrupt excision raises questions about the nutritional and physiological ramifications for subsequent generations.
The Endocannabinoid System: Biological Implications of Hemp’s Removal
Central to understanding hemp’s potential health impact is the endocannabinoid system (ECS), a sophisticated regulatory network identified in the early 1990s (Devane et al., 1992). Comprising endocannabinoids, CB1 and CB2 receptors, and metabolic enzymes, the ECS modulates immune responses, inflammation, and homeostasis (Pertwee, 2010). Hemp contains cannabinoids—notably cannabidiol (CBD) and trace tetrahydrocannabinol (THC)—which engage these receptors, potentially exerting anti-inflammatory and immunomodulatory effects (Russo, 2016). Historical consumption of hemp-fed livestock may have provided humans with a dietary source of these compounds via animal products, supporting ECS functionality (USDA ARS, 2023). The 1937 act’s elimination of this pathway could have diminished ECS resilience, rendering populations more susceptible to inflammatory and immune-related disorders, including allergies and certain cancers (Pertwee, 2010).
Nutritional Significance: Hemp as a Complete Protein Source
Beyond its cannabinoids, hemp offers exceptional nutritional value, particularly through its seeds. Hemp seeds constitute a complete protein, furnishing all nine essential amino acids—histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine—that humans must obtain exogenously (Callaway, 2004). Rich in glutamine and arginine, hemp protein rivals soy in amino acid profile while boasting superior digestibility (Callaway, 2004). Additionally, hemp seeds provide omega-3 and omega-6 fatty acids in an optimal ratio, alongside fiber, vitamin E, magnesium, and potassium, collectively bolstering cardiovascular, neurological, and digestive health (Rodriguez-Leyva and Pierce, 2010). The exclusion of such a nutrient-dense resource from livestock feed and human diets post-1937 may have precipitated a nutritional deficit, potentially exacerbating chronic disease prevalence (Callaway, 2004).
Health Trends: Correlating Hemp’s Absence with Disease Incidence
The 20th century witnessed a marked increase in cancer and allergy prevalence, trends that invite scrutiny of antecedent dietary and environmental shifts. Cancer incidence escalated across multiple categories, with data from the National Cancer Institute indicating a persistent rise adjusted for population growth, despite recent declines in smoking-related cases (Siegel et al., 2023). Concurrently, allergic conditions surged, with childhood food allergy prevalence increasing by 50% between 2007 and 2021, and peanut or tree nut allergies tripling from 1997 to 2008 (Sicherer et al., 2010). While multifactorial—encompassing improved diagnostics, hygiene hypotheses, and industrial diets—the temporal alignment with hemp’s removal suggests a plausible contributory role. The loss of ECS-supporting cannabinoids and essential nutrients may have heightened inflammatory responses and nutritional deficiencies, key precursors to these conditions (Russo, 2016; Sicherer et al., 2010).
Emerging Research: Cannabinoids and Therapeutic Potential
Contemporary investigations illuminate hemp’s latent health benefits, particularly through its cannabinoids. Preclinical studies demonstrate CBD’s capacity to suppress tumour proliferation and metastasis, though clinical applications remain confined to palliative care (Velasco et al., 2016). In allergic contexts, cannabinoids exhibit anti-inflammatory properties, reducing airway hypersensitivity and dermal irritation, suggesting a mitigative role in hypersensitivity disorders (Bielawiec et al., 2020). These findings, while nascent, underscore the physiological void left by hemp’s 1937 ban. Definitive causation linking its absence to modern health crises remains elusive, necessitating rigorous longitudinal research (Velasco et al., 2016; Bielawiec et al., 2020).
Conclusion: Reassessing Hemp’s Historical and Future Role
The Marihuana Tax Act of 1937, by excising hemp from the American food chain, may have unwittingly contributed to the 20th century’s health burdens. Its dual loss—nutritional richness and ECS-supporting cannabinoids—offers a compelling hypothesis for the rise in cancers and allergies, substantiated by emerging science and historical analysis (Russo, 2016; Callaway, 2004). The 2018 Farm Bill’s legalization of hemp cultivation presents an opportunity to reintegrate this versatile plant, potentially ameliorating these conditions. As scholars and practitioners, we must advocate for comprehensive studies to elucidate these connections, ensuring evidence-based policy and health strategies for future generations.
References
Bielawiec, P., Harasim-Symbor, E. and Chabowski, A., 2020. The role of cannabinoids in allergic diseases. International Archives of Allergy and Immunology, 181(8), pp.565-573.
Bonnie, R.J. and Whitebread, C.H., 1970. The forbidden fruit and the tree of knowledge: An inquiry into the legal history of American marijuana prohibition. Virginia Law Review, 56(6), pp.971-1203.
Callaway, J.C., 2004. Hempseed as a nutritional resource: An overview. Euphytica, 140(1), pp.65-72.
Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. and Mechoulam, R., 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258(5090), pp.1946-1949.
Gieringer, D.H., 1985. The forgotten origins of cannabis prohibition in California. Contemporary Drug Problems, 12(2), pp.123-143.
Pertwee, R.G., 2010. Cannabinoid receptors and their ligands: Beyond CB1 and CB2. Pharmacological Reviews, 62(4), pp.588-631.
Rodriguez-Leyva, D. and Pierce, G.N., 2010. The cardiac and haemostatic effects of dietary hempseed. Nutrition & Metabolism, 7(1), p.32.
Russo, E.B., 2016. Clinical endocannabinoid deficiency reconsidered: Current research supports the theory in migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes. Cannabis and Cannabinoid Research, 1(1), pp.154-165.
Sicherer, S.H., Muñoz-Furlong, A., Godbold, J.H. and Sampson, H.A., 2010. US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. Journal of Allergy and Clinical Immunology, 125(6), pp.1322-1326.
Siegel, R.L., Miller, K.D., Wagle, N.S. and Jemal, A., 2023. Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73(1), pp.17-48.
USDA, 1935. Farmers’ Bulletin No. 1935: Hemp. Washington, DC: United States Department of Agriculture.
USDA ARS, 2023. USDA scientists determine that feeding hempseed cakes to cattle does not pose food safety risk. Food Safety Magazine, [online] Available at: https://www.food-safety.com/articles/8512 [Accessed 3 April 2025].
Velasco, G., Sánchez, C. and Guzmán, M., 2016. Anticancer mechanisms of cannabinoids. British Journal of Cancer, 114(6), pp.565-573.
